| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |